Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02NVF
|
||||
| Former ID |
DIB002829
|
||||
| Drug Name |
M-241247
|
||||
| Synonyms |
M-241247; M-244249; NMDA/glycine antagonists, Zeneca
|
||||
| Indication | Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] | Terminated | [1] | ||
| Company |
Zeneca Group plc
|
||||
| Target and Pathway | |||||
| Target(s) | Glycine receptor | Target Info | Antagonist | [2] | |
| NMDA receptor | Target Info | Antagonist | [2] | ||
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Reactome | Ligand-gated ion channel transport | ||||
| WikiPathways | Iron uptake and transport | ||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003415) | ||||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003415) | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.